{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477224937
| IUPAC_name = 2-(5-Methoxy-1''H''-indol-3-yl)-''N'',''N''-dimethylethan-2-amine
| image = 5-MeO-DMT.svg
| width = 160
| image2 = 5-MeO-DMT-3d-sticks.png
| width2 = 180

<!--Clinical data-->
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU = S9
| legal_CA =
| legal_UK = Class A
| legal_US = Schedule I
| legal_DE = Anlage I
| legal_status = Illegal in China, Sweden, Turkey
| routes_of_administration = Smoked, Insufflated, Oral

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 1019-45-0
| ATC_prefix =
| ATC_suffix =
| PubChem = 1832
| IUPHAR_ligand = 145
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 1766
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = X0MKX3GWU9
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = C08309
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 2086
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 7257

<!--Chemical data-->
| C=13 | H=18 | N=2 | O=1
| smiles = O(c1cc2c(cc1)ncc2CCN(C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H18N2O/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZSTKHSQDNIGFLM-UHFFFAOYSA-N
| melting_point =
| melting_high =
}}

'''5-MeO-DMT''' ('''5-methoxy-''N'',''N''-dimethyltryptamine''') is a [[psychedelic drug|psychedelic]] of the [[Substituted tryptamine|tryptamine]] class. It is found in a [[List of psychedelic plants|wide]] [[biodiversity|variety]] of [[plant]] [[species]], and a single [[psychoactive toad]] species, the [[Colorado River toad]]. Like its close relatives [[Dimethyltryptamine|DMT]] and [[bufotenin]] (5-HO-DMT), it has been used as an [[entheogen]] in [[South America]].<ref>{{cite journal|first1=AnaMargarida|last1=Araújo|first2=Félix|last2=Carvalho|first3=Maria deLourdes|last3=Bastos|first4=Paula|last4=Guedes de Pinho|title=The hallucinogenic world of tryptamines: an updated review|url=https://link.springer.com/article/10.1007/s00204-015-1513-x|journal=Archives of Toxicology|date=August 2015|issn=0340-5761|pages=1151–1173|volume=89|issue=8|doi=10.1007/s00204-015-1513-x|pmid=25877327|first5=Márcia|last5=Carvalho}}</ref>

==Chemistry==
5-MeO-DMT was first [[Organic synthesis|synthesized]] in 1936, and in 1959 it was isolated as one of the [[Psychoactive drug|psychoactive]] ingredients of ''[[Anadenanthera peregrina]]'' [[seed]]s used in preparing [[Anadenanthera peregrina|Yopo]] snuff. It was once believed to be a major component of the psychoactive [[neuropsychopharmacology|effects]] of the snuff, although this has recently been shown to be unlikely, due to the limited or sometimes even non-existent quantity contained within the seeds, which instead achieve their psychoactivity from the ''O''-[[Demethylation|demethylated]] [[metabolite]] of 5-MeO-DMT, [[bufotenin]].<ref>{{cite journal|first1=Jonathan|last1=Ott|title=Pharmañopo—Psychonautics: Human Intranasal, Sublingual, Intrarectal, Pulmonary and Oral Pharmacology of Bufotenine|url=http://www.tandfonline.com/doi/abs/10.1080/02791072.2001.10400574|journal=Journal of Psychoactive Drugs|date=July–September 2001|issn=0279-1072|pages=273–281|volume=33|issue=3|pmid=11718320|doi=10.1080/02791072.2001.10400574}}</ref><ref name=Shen/> It is [[metabolism|metabolized]] mainly by [[CYP2D6]].<ref name=Shen>{{cite journal|first1=Hong-Wu|last1=Shen|first2=Xi-Ling|last2=Jiang|first3=Jerrold C.|last3=Winter|first4=Ai-Ming|last4=Yu|title=Psychedelic 5-Methoxy-''N'',''N''-dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions|journal=Current Drug Metabolism|date=October 2010|issn=1389-2002|pages=659–666|volume=11|issue=8|pmid=20942780|pmc=3028383|doi=10.2174/138920010794233495}}</ref>

==Religious use==

5-MeO-DMT is a [[sacrament]] of the [[Church of the Tree of Life]]. From approximately 1971 to the late 1980s, 5-MeO-DMT was discreetly available to its members.<ref name="Erowid">{{cite web |url=https://www.erowid.org/chemicals/5meo_dmt/5meo_dmt_timeline.php |title=5-MeO-DMT Timeline |work=Erowid}}</ref> Between 1970 and 1990 smoking of 5-MeO-DMT on [[parsley]] was probably one of the two most common forms of [[route of administration|ingestion]] in the [[United States]].<ref name="Erowid"/>

==Pharmacology==
5-MeO-DMT is a [[Methoxylation|methoxylated]] [[derivative (chemistry)|derivative]] of [[Dimethyltryptamine|DMT]]. Its [[pharmacology|pharmacological]] [[pharmacological activity|action]] is mainly through [[5-HT receptor|serotonin receptors]]. Specifically, it shows high [[Affinity (pharmacology)|affinity]] for the [[5-HT2 receptor|5-HT<sub>2</sub>]] and [[5-HT1A receptor|5-HT<sub>1A</sub>]] subtypes.<ref>{{cite journal|first1=Kirsten|last1=Krebs-Thomson|first2=ErbertM.|last2=Ruiz|first3=Virginia|last3=Masten|first4=Mahalah|last4=Buell|title=The roles of 5-HT<sub>1A</sub> and 5-HT<sub>2</sub> receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats|url=https://link.springer.com/article/10.1007/s00213-006-0566-1|journal=Psychopharmacology|date=December 2006|issn=0033-3158|pages=319–329|volume=189|issue=3|doi=10.1007/s00213-006-0566-1|pmid=17013638|first5=MarkA.|last5=Geyer}}</ref>
Additional [[mechanism of action|mechanisms of action]] such as [[reuptake inhibitor|inhibition]] of [[monoamine]] [[reuptake]] may be involved also.<ref>{{cite journal|first1=Fumiko|last1=Nagai|first2=Ryouichi|last2=Nonaka|first3=Kanako|last3=Satoh Hisashi Kamimura|title=The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain|url=http://www.sciencedirect.com/science/article/pii/S0014299906013811|journal=European Journal of Pharmacology|date=22 March 2007|pages=132–137|volume=559|issue=2–3|doi=10.1016/j.ejphar.2006.11.075|pmid=17223101}}</ref>

==Legal status==

===China===

As of October 2015, 5-MeO-DMT is a [[controlled substance]] in [[China]].<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

===Australia===
As a [[structural analog]] of ''N'',''N''-dimethyltryptamine (DMT), 5-MeO-DMT is a Schedule 9 prohibited substance under the [[Standard for the Uniform Scheduling of Medicines and Poisons|Poisons Standard]].<ref>{{cite web | url=https://www.legislation.gov.au/Details/F2016L01071 | title=Poisons Standard July 2016 | publisher=Federal Register of Legislation}}</ref>

===Sweden===
[[Riksdag|''Sveriges riksdags'']] health ministry [[:sv:Statens folkhälsoinstitut|''Statens folkhälsoinstitut'']] classified 5-MeO-DMT, listed as '''5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)''' in their regulation '''SFS 2004:696''',  as "health hazard" under the act [[:sv:Lagen om förbud mot vissa hälsofarliga varor|''Lagen om förbud mot vissa hälsofarliga varor'']] (translated ''Act on the Prohibition of Certain Goods Dangerous to Health'') in October 2004, making it illegal to sell or possess.<ref>{{cite web | url=https://www.notisum.se/rnp/sls/sfs/20040696.pdf | title=Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor | work=Svensk författningssamling | date=7 September 2004 | language=sv}}</ref>

===Turkey===
5-MeO-DMT has been controlled in [[Turkey]] since December 2013.<ref>{{cite web | url=http://www.resmigazete.gov.tr/eskiler/2014/01/20140125-3-1.pdf | title=Turkish Law | work=Resmi Gazete | date=16 December 2013}}</ref>

===US===
5-MeO-DMT was made a [[List of Schedule I drugs (US)|Schedule I]] [[Controlled Substances Act|controlled substance]] in January 2011.<ref>{{cite journal|last1=Drug Enforcement Administration (DEA), Department of Justice|title=Schedules of Controlled Substances: Placement of 5-Methoxy-N,N-Dimethyltryptamine into Schedule I of the Controlled Substances Act|url=https://www.gpo.gov/fdsys/pkg/FR-2010-12-20/pdf/2010-31854.pdf|journal=Federal Register|date=20 December 2010|issn=0097-6326|pages=79296–79300|volume=75|issue=243|pmid=21171485}}</ref>

== See also ==
* [[4-MeO-DMT]]
* [[5-MeO-AMT]]
* [[5-MeO-DIPT]]
* [[5-EtO-DMT]]
* [[Dimemebfe]]
* [[List of entheogens]]

== References ==
{{Reflist|30em}}

==External links==
* [https://www.erowid.org/library/books_online/tihkal/tihkal38.shtml TiHKAL #38 on Erowid] and [https://www.erowid.org/chemicals/5meo_dmt/5meo_dmt.shtml Erowid's 5-MeO-DMT Vault]
* [https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=38 5-MeO-DMT Entry in TiHKAL • info]
* 
* [https://5meodmt.org 5 Hive - 5-MeO-DMT Forum]
* [https://psychonautwiki.org/wiki/5-MeO-DMT PsychonautWiki's 5-meo-dmt]

{{Hallucinogens}}
{{Serotonin receptor modulators}}
{{Sigma receptor modulators}}
{{Tryptamines}}
{{TiHKAL}}

{{DEFAULTSORT:MeO-DMT, 5-}}

[[Category:Ayahuasca]]
[[Category:Entheogens]]
[[Category:Psychedelic tryptamines]]
[[Category:Tryptamine alkaloids]]
[[Category:Phenol ethers]]
[[Category:Serotonin receptor agonists]]
[[Category:Psychedelic drugs]]
[[Category:Designer drugs]]